Investors Alert: Class Action Lawsuit Filed Against ASP Isotopes Inc.

The Schall Law Firm, a reputable national shareholder rights litigation firm, is alerting investors about a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) ASPI. The lawsuit alleges violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 implemented by the U.S. Securities and Exchange Commission.

Important Dates for Investors

Investors who acquired the Company’s securities between October 30, 2024, and November 26, 2024, inclusive (the “Class Period”), should reach out to the firm before February 3, 2025.

If you are a shareholder who has experienced losses, click here to participate.

Contact Information for Legal Assistance

We invite you to speak with Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. His phone number is 310-301-3335. You may also contact us via our website at www.schallfirm.com or email bschall@schallfirm.com.

Understanding Class Membership

Please note that the class in this case has not yet been certified. Until certification occurs, you are not represented by an attorney. Those who choose not to take action can remain absent class members.

Claims Against ASP Isotopes

The Complaint claims that the Company made false and misleading statements to investors. Specifically, ASP Isotopes overstated the effectiveness of its enrichment technology, falsely promoted the potential of its high assay low-enriched uranium facility, and inflated the performance of its nuclear fuels operating segment. As a result, the Company’s public statements were deemed materially misleading during the class period, leading to investor losses when the truth emerged.

Joining the Lawsuit

Take action to reclaim your losses by joining this case.

The Schall Law Firm has a global presence and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may qualify as Attorney Advertising based on the applicable laws and rules of ethics in various jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241205121419/en/